Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bon Natural LifeBON -0.87%44 Equity-to-Asset is 0.68 as of Sep. 2025, which is 1% below its 10-year median of 0.69. GuruFocus rates BON with a GF Score™ of 44/100 and a GF Value™ of $0.75 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,615 Chemicals companies, Bon Natural Life ranks better than 64.27% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bon Natural Life's Total Stockholders Equity for the quarter that ended in Sep. 2025 was $57.55 Mil. Bon Natural Life's Total Assets for the quarter that ended in Sep. 2025 was $85.19 Mil.
Therefore, Bon Natural Life's Equity to Asset Ratio for the quarter that ended in Sep. 2025 was 0.68.
The historical rank and industry rank for Bon Natural Life's Equity-to-Asset or its related term are showing as below:
BON'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27 Med: 0.69 Max: 0.79
Current: 0.68
During the past 8 years, the highest Equity to Asset Ratio of Bon Natural Life was 0.79. The lowest was 0.27. And the median was 0.69.
BON's Equity-to-Asset is ranked better than 64.27% of 1615
companies
in the Chemicals industry
Industry Median: 0.6
vs BON: 0.68
Bon Natural Life (NAS:BON) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bon Natural Life Equity-to-Asset Related Terms
Bon Natural Life Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Bon Natural Life's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BON vs SNES, YMAT, GLGI: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, Bon Natural Life's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bon Natural Life's Equity to Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life (BON) has a Equity-to-Asset of 0.68 as of Sep. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bon Natural Life and its competitors. This is near median its historical median of 0.69. Over the past decade, Bon Natural Life's Equity-to-Asset has ranged from 0.27 to 0.79. According to the industry distribution chart, Bon Natural Life ranks #577 out of 1615 companies in the Chemicals industry, placing it in the top 35.7%.
Is Bon Natural Life's Equity-to-Asset too high?
Bon Natural Life's current Equity-to-Asset of 0.68 is near median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 0.79. The Chemicals industry median Equity-to-Asset is 0.60. Bon Natural Life's value of 0.68 is 13.3% above this industry median. Based on the distribution chart, Bon Natural Life ranks #577 out of 1615 companies in the Chemicals industry, which is above the industry midpoint. Overall, Bon Natural Life has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's Equity-to-Asset compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #577 out of 1615 companies for Equity-to-Asset. This puts Bon Natural Life in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Bon Natural Life's value of 0.68 is 13.3% above this benchmark. Historically, Bon Natural Life's own Equity-to-Asset has ranged from 0.27 to 0.79 over the past decade. While the company's 10-year median is 0.69 vs. the industry median of 0.60, Bon Natural Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,615 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bon Natural Life's current Equity-to-Asset of 0.68 is 13.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bon Natural Life and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bon Natural Life's current Equity-to-Asset is 0.68, which is near median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.75, compared to a current price of $1.14 — trading 52% above its estimated fair value. The current Equity-to-Asset is 0.68, which is near median its 10-year median of 0.69 and 13.3% above the Chemicals industry median of 0.60. Bon Natural Life's overall GF Score™ is 44/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bon Natural Life (BON), the current Equity-to-Asset is 0.68 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 52% above its estimated GF Value™ of $0.75.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
Equity-to-Asset: 0.68 (near median its 10-year median of 0.69)
GF Value™: $0.75 vs. price of $1.14 (52% above fair value)
Industry Position: 13.3% above the Chemicals median (#577 of 1615)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
44GF Score
Get the complete analysis for BON
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
